Sencilia
Sencilia develops non-contact sensor technology (Rely-V®) to monitor intravenous drug delivery in vulnerable patient populations, currently in pre-clinical development phase.
Sencilia is pioneering next-generation NICU monitoring technology using advanced MEMS sensor architectures to address flow rate errors in pediatric and neonatal intensive care. The company's Rely-V® program focuses on detecting changes in low-flow infusions to prevent adverse drug events in fragile patients.
Key People
- Amar M. Kamat - Founder and CEO
- Ajay G.P. Kottapalli - Scientific Founder and Advisor